BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 24385269)

  • 1. Implementation of a structured guideline-based program for the secondary prevention of ischemic stroke in China.
    Peng B; Ni J; Anderson CS; Zhu Y; Wang Y; Pu C; Wu J; Wang J; Zhou L; Yao M; He J; Shan G; Gao S; Xu W; Cui L;
    Stroke; 2014 Feb; 45(2):515-9. PubMed ID: 24385269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Standard medical management in secondary prevention of ischemic stroke in China (SMART).
    Peng B; Zhu Y; Cui L; Ni J; Xu W; Zhou L; Yao M; Chen L; Wang J; Wang Y; Pu C;
    Int J Stroke; 2011 Oct; 6(5):461-5. PubMed ID: 21951412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of a Multifaceted Quality Improvement Intervention on Hospital Personnel Adherence to Performance Measures in Patients With Acute Ischemic Stroke in China: A Randomized Clinical Trial.
    Wang Y; Li Z; Zhao X; Wang C; Wang X; Wang D; Liang L; Liu L; Wang C; Li H; Shen H; Bettger J; Pan Y; Jiang Y; Yang X; Zhang C; Han X; Meng X; Yang X; Kang H; Yuan W; Fonarow GC; Peterson ED; Schwamm LH; Xian Y; Wang Y;
    JAMA; 2018 Jul; 320(3):245-254. PubMed ID: 29959443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of secondary medical prophylaxis and clinical outcome among patients with ischemic stroke: a nationwide follow-up study.
    Palnum KH; Mehnert F; Andersen G; Ingeman A; Krog BR; Bartels PD; Johnsen SP
    Stroke; 2012 Mar; 43(3):802-7. PubMed ID: 22207506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adherence to secondary prevention medications and four-year outcomes in outpatients with atherosclerosis.
    Kumbhani DJ; Steg PG; Cannon CP; Eagle KA; Smith SC; Hoffman E; Goto S; Ohman EM; Bhatt DL;
    Am J Med; 2013 Aug; 126(8):693-700.e1. PubMed ID: 23800583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Secondary prevention of ischemic non cardioembolic stroke].
    Armario P; Pinto X; Soler C; Cardona P
    Clin Investig Arterioscler; 2015; 27(6):287-300. PubMed ID: 25771074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A survey on compliance with secondary stroke prevention guidelines and follow up for the inpatients with atherosclerotic cerebral infarction/transient ischemic attack.
    Ma R; Wang C; Zhao X; Xu M; Lv Y; Wei M; Cai Y; Zhang Z; Wang L; Zhang W; Huang Y; Li Y; Li H; Wang Y
    Neurol Res; 2008 May; 30(4):383-8. PubMed ID: 18544256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utility of a post-hospitalization stroke prevention program managed by nurses.
    Flemming KD; Allison TG; Covalt JL; Herzig DE; Brown RD
    Hosp Pract (1995); 2013 Aug; 41(3):70-9. PubMed ID: 23948623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A guideline-based program may improve the outcome of stroke among illiterate patients.
    Ni J; Yao M; Zhou L; Zhu Y; Peng B; Cui L;
    Int J Stroke; 2016 Apr; 11(3):332-7. PubMed ID: 26780948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implementation of a new guideline in cardiovascular secondary preventive care: subanalysis of a randomized controlled trial.
    Jakobsson S; Huber D; Björklund F; Mooe T
    BMC Cardiovasc Disord; 2016 Apr; 16():77. PubMed ID: 27129980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Derivation and Application of a Tool to Estimate Benefits From Multiple Therapies That Reduce Recurrent Stroke Risk.
    Richards A; Jackson NJ; Cheng EM; Bryg RJ; Brown A; Towfighi A; Sanossian N; Barry F; Li N; Vickrey BG
    Stroke; 2020 May; 51(5):1563-1569. PubMed ID: 32200759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term adherence to national guidelines for secondary prevention of ischemic stroke: a prospective cohort study in a public hospital in Chile.
    Muñoz-Venturelli P; Sacks C; Madrid E; Lavados PM
    J Stroke Cerebrovasc Dis; 2014 Mar; 23(3):490-5. PubMed ID: 23680688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation on the compliance with secondary prevention and influence factors of ischemic stroke in Hainan province, China.
    Su Q; Yuan K; Long F; Wan Z; Li C; Cai Y; Zeng C; Wu Y; Wu H; Liu S; Li P; Zhou J; Chen C; Wang D; Yan L; Zhang Y; Dai M
    Vascular; 2014 Jun; 22(3):181-7. PubMed ID: 23929417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ischemic stroke in patients receiving aspirin.
    Pujol Lereis VA; Ameriso S; Povedano GP; Ameriso SF
    J Stroke Cerebrovasc Dis; 2012 Nov; 21(8):868-72. PubMed ID: 21703876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Limited Efficacy of a Long-term Secondary Prevention Program in Ischemic Stroke and Transient Ischemic Attack Patients.
    Van Schaik SM; Van den Berg-Vos RM; Weinstein HC; Bosboom WM
    J Stroke Cerebrovasc Dis; 2015 Jun; 24(6):1378-82. PubMed ID: 25804570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical outcomes using a platelet function-guided approach for secondary prevention in patients with ischemic stroke or transient ischemic attack.
    Depta JP; Fowler J; Novak E; Katzan I; Bakdash S; Kottke-Marchant K; Bhatt DL
    Stroke; 2012 Sep; 43(9):2376-81. PubMed ID: 22713488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Time-Varying Effects of Prasugrel Versus Clopidogrel on the Long-Term Risks of Stroke After Acute Coronary Syndromes: Results From the TRILOGY ACS Trial.
    Chin CT; Neely B; Magnus Ohman E; Armstrong PW; Corbalán R; White HD; Prabhakaran D; Winters KJ; Fox KA; Roe MT;
    Stroke; 2016 Apr; 47(4):1135-9. PubMed ID: 26883498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rationale and design of a randomized cluster trial to improve guideline-adherence of secondary preventive drugs prescription after coronary artery bypass grafting in China: Measurement and Improvement Studies of Surgical Coronary Revascularization: Secondary Prevention (MISSION-1) Study.
    Rao C; Du J; Li X; Li J; Zhang H; Zhao Y; Hu S; Jiang L; Zheng Z;
    Am Heart J; 2016 Aug; 178():9-18. PubMed ID: 27502847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of a health promotion program on medication adherence to antiplatelet therapy among ischemic stroke patients in Hainan Province, China.
    Su Q; Li C; Long F; Chen B; Wan Z; Wu Y; Dai M; Wang D; Zhang Y; Wang B
    Vascular; 2017 Jun; 25(3):242-248. PubMed ID: 27580820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High on-treatment platelet reactivity as a risk factor for secondary prevention after coronary stent revascularization: A landmark analysis of the ARCTIC study.
    Montalescot G; Rangé G; Silvain J; Bonnet JL; Boueri Z; Barthélémy O; Cayla G; Belle L; Van Belle E; Cuisset T; Elhadad S; Pouillot C; Henry P; Motreff P; Carrié D; Rousseau H; Aubry P; Monségu J; Sabouret P; O'Connor SA; Abtan J; Kerneis M; Saint-Etienne C; Beygui F; Vicaut E; Collet JP;
    Circulation; 2014 May; 129(21):2136-43. PubMed ID: 24718568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.